Matrix metalloproteinase inhibition during the development of congestive heart failure - Effects on left ventricular dimensions and function

被引:276
|
作者
Spinale, FG
Coker, ML
Krombach, SR
Mukherjee, R
Hallak, H
Houck, WV
Clair, MJ
Kribbs, SB
Johnson, LL
Peterson, JT
Zile, MR
机构
[1] Med Univ S Carolina, Div Cardiothorac Surg, Charleston, SC 29425 USA
[2] Parke Davis & Co, Cardiovasc Pharmacol, Ann Arbor, MI USA
关键词
congestive heart failure; metalloproteinases; myocyte function;
D O I
10.1161/01.RES.85.4.364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of congestive heart failure (CHF) is associated with left ventricle(LV) dilation and myocardial remodeling. The matrix metalloproteinases (MMPs) play a significant role in extracellular remodeling, and recent studies have demonstrated increased MMP expression and activity with CHF. Whether increased MMP activity directly contributes to the LV remodeling with CHF remains unknown. Accordingly, this study examined the effects of chronic MMP inhibition (MMPi) on LV size and function during the progression of CHF. Pigs were assigned to the following groups: (1) CHF, rapid pacing for 3 weeks at 240 bpm (n=12); (2) CHF/MMPi rapid pacing and concomitant MMPi (PD166793, 20 mg/kg per day [n=10]), and (3) control (n=11). With pacing CHF, LV fractional shortening was reduced (19+/-1 versus 45+/-1%), and end-diastolic dimension increased (5.67+/-0.11 versus 3.55+/-0.05 cp),compared with baseline values (P<0.05). In the CHF/MMPi group, LV endocardial shortening increased (25+/-2%) and the end-diastolic dimension was reduced (4.92+/-0.17 cm) compared with CHF-only values (P<0.05). LV midwall shortening was reduced to a comparable degree in the CHF-only and CHF/MMPi groups. LV peak wall stress increased 3-fold with pacing CHF compared with controls and was significantly reduced in the CHF/MMPi group. LV myocardial stiffness was unchanged with CHF but was increased in the CHF/MMPi group. LV myocyte length was increased with pacing CHF compared with controls (180+/-3 versus 125+/-4 mu m, P<0.05) and was reduced in the CHF/MMPi group (169+/-4 mu m, P<0.05). Basal-state myocyte shortening velocity was reduced with pacing CHF compared with controls (33+/-2 versus 66+/-1 mu m/s, P<0.05) and was unchanged in the CHF/MMPi group (31+/-2 mu m/s). Using an ex vivo assay system, myocardial MMP activity was increased with pacing CHF and was reduced with chronic MMPi. In summary, concomitant MMPi with developing CHF limited LV dilation and reduced wall stress. These results suggest that increased myocardial MMP activity contributes to LV myocardial remodeling in developing CHF.
引用
收藏
页码:364 / 376
页数:13
相关论文
共 50 条
  • [1] Matrix metalloproteinase inhibition with congestive heart failure improves left ventricular geometry and pump function
    Spinale, FG
    Krombach, RS
    Coker, ML
    Mukherjee, R
    Houck, WV
    Clair, MJ
    Kribbs, SB
    Hebbar, L
    Peterson, JT
    CIRCULATION, 1997, 96 (08) : 2915 - 2915
  • [2] Selective matrix metalloproteinase inhibition with developing heart failure - Effects on left ventricular function and structure
    King, MK
    Coker, ML
    Goldberg, A
    McElmurray, JH
    Gunasinghe, HR
    Mukherjee, R
    Zile, MR
    O'Neill, TP
    Spinale, FG
    CIRCULATION RESEARCH, 2003, 92 (02) : 177 - 185
  • [3] Combined angiotensin converting enzyme and matrix metalloproteinase inhibition with developing heart failure: Effects on left ventricular function and geometry
    Spinale, FG
    McElmurray, JH
    Mukherjee, R
    New, BR
    Sampson, AC
    King, MK
    Hendrick, JW
    Patterson, TM
    Peterson, JT
    Zile, MR
    CIRCULATION, 1999, 100 (18) : 647 - 647
  • [4] Effects of ivabradine on left ventricular function in dogs with congestive heart failure
    Sri-ngam, Sajika
    Petchdee, Soontaree
    THAI JOURNAL OF VETERINARY MEDICINE, 2017, 47 (01): : 71 - 78
  • [5] Matrix metalloproteinase in left ventricular remodeling and heart failure
    Suresh Shastry
    Melvin R. Hayden
    Pamela A. Lucchesi
    Suresh C. Tyagi
    Current Cardiology Reports, 2003, 5 (3) : 200 - 204
  • [6] Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: Comparative effects on left ventricular function and geometry
    McElmurray, JH
    Mukherjee, R
    New, RB
    Sampson, AC
    King, MK
    Hendrick, JW
    Goldberg, A
    Peterson, TJ
    Hallak, H
    Zile, MR
    Spinale, FG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 291 (02): : 799 - 811
  • [7] Selective matrix metalloproteinase inhibition influences LV function and geometry with developing congestive heart failure
    King, MK
    Coker, ML
    Goldberg, AT
    Morrison, AE
    McElmurray, JH
    Gunasinghe, HR
    Mukherjee, R
    Wendt, KA
    O'Neill, TP
    Zile, MR
    Spinale, FG
    CIRCULATION, 2000, 102 (18) : 452 - 452
  • [8] Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure
    Houck, WV
    Pan, LC
    Kribbs, SB
    Clair, MJ
    McDaniel, GM
    Krombach, RS
    Merritt, WM
    Pirie, C
    Iannini, JP
    Mukherjee, R
    Spinale, FG
    CIRCULATION, 1999, 100 (19) : 2003 - 2009
  • [9] Dual metalloprotease inhibition during the development of left ventricular failure; Effects on left ventricular and myocyte function and geometry
    Thomas, CV
    Holzgrefe, HH
    Mukherjee, R
    Hird, RB
    Walker, JD
    Hebbar, L
    Arthur, SR
    Powell, JR
    Spinale, FG
    CIRCULATION, 1997, 96 (08) : 2935 - 2935
  • [10] Congestive heart failure with Normal left ventricular systolic function
    Preobrazhensky, DV
    Sidorenko, BA
    Shatunova, IM
    Aleksandrova, AU
    KARDIOLOGIYA, 2001, 41 (01) : 85 - 91